Wasif M. Saif, MD, MBBS, discusses recommendations for germline testing in patients with pancreatic cancer.
Wasif Saif, MD
Advertisement
Articles by Wasif Saif, MD
Wasif M. Saif, MD, MBBS, discusses the rationale to utilize PARP inhibitors in BRCA-mutated pancreatic cancer.
Advertisement
Latest Updated Articles
Dr. Saif on Recommendations for Germline Testing in Pancreatic CancerPublished: November 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5